Short interest in Ovid Therapeutics Inc (NASDAQ:OVID) decreased during the last reporting period, falling from 803.16K to 721.30K. This put 1.23% of the company's publicly available shares short.

Short interest for Ovid Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Ovid Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 238.29K shares traded per day, it would take 3.03 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.